A prospective randomized controlled trial of preoperative transarterial chemoembolisation for resectable large hepatocellular carcinoma Ann Surg 2009; 249: 195-202

Published: 1st January 2009

Authors: Zhou W-P, Lai ECH, Li A-J, Fu S-Y, Zhou J-Ppan Z-y et al

Conclusion

Five of the initial 56 patients that had embolisation did not proceed to surgery. Surgery took longer in those that had preoperative chemoembolisation (176 vs. 149 min, P=0.042). After a median of 57 months, outcomes were similar in both the treatment and control groups: disease-free survival 13 vs. 9 per cent, and survival 31 vs. 21 per cent, respectively.

Pubmed Link

Your comments

0 Comments